Quillichew Er(Methylphenidate Hcl)
Medicare prescription drug cost, prescriptions and prescribers, 2024
$285K
Medicare cost, 2024
$285K
Medicare cost, 2024
Medicare drug plans spent $285,029 on Quillichew Er (methylphenidate hcl) in 2024, for 644 prescriptions and refills filled by 110 patients. North Carolina accounts for the most spending ($29,367, 10% of the total).
Medicare cost, 2024
$285K
+9.5% from 2023
Prescriptions
644
$442.59 per claim
Patients
110
155 prescribers
Total spending, 2024
$285K
$2,591.17 per patient
Questions and answers
How much does Medicare spend on Quillichew Er?
Medicare prescription drug plans paid $285K for Quillichew Er in 2024, for 644 prescriptions and refills to 110 patients (up 9.5% from 2023). The average cost per claim was $442.59.
Which state spends the most on Quillichew Er?
North Carolina had the highest Medicare cost for Quillichew Er in 2024: $29K for 56 claims, followed by Maine ($18K).
Who prescribes Quillichew Er the most?
Paige N McInerney, psychiatry in Augusta, ME, had the highest Medicare cost for Quillichew Er in 2024: 26 claims costing $13K.
Spending over the years
Medicare spending by year
All plans and makers
Prescriber data: cost by year
Medicare spending on Quillichew Er was $285K in 2024, the highest year shown.
By state
Where the prescribers practice, 2024
Medicare cost by state
States with the highest cost
Top prescribers of Quillichew Er, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Paige N McInerney Augusta, ME | Psychiatry | 26 | Under 11 | $13K |
| Joanne C Decelles Greenville, NC | Nurse Practitioner | 12 | Under 11 | $9,122 |
| Gwynn Stup Dover, DE | Nurse Practitioner | 25 | Under 11 | $8,840 |
| Lisa M Slimmer Pittsford, NY | Psychiatry | 12 | Under 11 | $8,799 |
| 1790138873 | Nurse Practitioner | 16 | Under 11 | $6,006 |
| Nicholas Kramer Goshen, IN | Psychiatry | 12 | Under 11 | $5,082 |
| Christina J Crawford Omaha, NE | Nurse Practitioner | 13 | Under 11 | $4,919 |
| Jeff Priddy Charleston, WV | Psychiatry | 12 | Under 11 | $4,609 |
| Hanno P Muellner Williamsburg, MA | Internal Medicine | 12 | Under 11 | $4,439 |
| Katelin J Williamson Columbia, SC | Psychiatry | 11 | Under 11 | $4,329 |
| Mylan V Kohler De Pere, WI | Psychiatry | 11 | Under 11 | $4,259 |
| Larry C Sexton Augusta, ME | Nurse Practitioner | 11 | Under 11 | $4,258 |
| Irfan Ahmed Toledo, OH | Psychiatry | 11 | Under 11 | $4,089 |
| Donald E Hauser Bellaire, TX | Psychiatry | 11 | Under 11 | $3,799 |
| Katherine E Whittington Alcoa, TN | Nurse Practitioner | 11 | Under 11 | $2,014 |
Prescriber data by year
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 92 | 414 | 64 | $201K |
| 2023 | 121 | 540 | 88 | $260K |
| 2024 | 155 | 644 | 110 | $285K |
Makers, 2024
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Tris Pharma Inc | 644 | $285K |
Medicaid spending by quarter
Amount reimbursed by state Medicaid programs, all states
Amount reimbursed
Codes
- National drug codes (packages)
- 6
- Application numbers
- NDA207960
More drugs: Medicare drug spending and the Prescriptions view.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
Through September 2026, 60,702 side-effect reports named methylphenidate hydrochloride, the active ingredient of Quillichew Er (reports from 2003 on). 37,008 of them (61.0%) were serious, 2,752 named a death and 12,393 named a hospital stay. The reactions named most often were drug ineffective, fatigue and nausea. 17,492 reports came in the last 5 years (since 2022).
How to read these numbers
- A report shows that a patient, doctor or drug company suspected a link. It does not prove that the drug caused the effect.
- Counts are not risk rates. They depend on how many people use the drug, how long it has been sold, news and reporting habits, so they do not show which drug is safer.
- The newest months are partial: reports keep arriving late.
Reports, all years
60,702
3,799 in 2025 (+2.5% from 2024)
Serious
61.0%
37,008 reports
Deaths named
2,752
4.5% of reports
Hospital stays
12,393
20.4% of reports
Reports by year
Serious reports include those that name a death, a hospital stay, a disability or another serious outcome.
Reports received by year
2026 is the year so far.
Reports naming a death or a hospital stay
One report can name both
Reactions
Reactions named most often
All years. Share = part of all reports in that period. A report can name several reactions.
Patients
As given in the reports; many reports leave sex or age out.
Sex of the patient
All years
Age of the patient
Age when the effect started, all years
Questions and answers
How many side-effect reports name Quillichew Er?
60,702 reports from 2003 through September 2026 named methylphenidate hydrochloride, the active ingredient of Quillichew Er. 37,008 of them (61.0%) were serious, 2,752 named a death and 12,393 named a hospital stay.
What are the most reported side effects of Quillichew Er?
6,255 reports named drug ineffective, the reaction named most often, followed by fatigue (3,258) and nausea (3,056). In the last 5 years the reaction named most often was drug ineffective (2,250 reports). A report can name several reactions.
How many side-effect reports named Quillichew Er in 2025?
3,799 reports were received in 2025 (+2.5% from 2024). 2026 so far: 2,837 reports through September 2026, and more keep arriving late.
Do side-effect reports prove that Quillichew Er caused a problem?
No. A report shows that a patient, doctor or drug company suspected a link; it does not prove that Quillichew Er caused the effect. Report counts depend on how widely a drug is used, how long it has been sold, news and reporting habits, so they are not risk rates and do not show which drug is safer.
Related pages
- Other Medicare drug pages with methylphenidate hydrochloride: Concerta, Ritalin, Ritalin La, Quillivant Xr, Relexxii, Methylin
- Makers on the stock market:
4507.T
JNJ·4507.T drug pipeline - Drug approvals (7 approvals on file for methylphenidate hydrochloride) · Clinical trials · Medicare drug spending
Side-effect reports from official public data, counted per active ingredient (methylphenidate hydrochloride) by the year the report was received, so the brand and generic pages of one ingredient show the same reports. A report can name several drugs and several reactions and counts for each. Reaction names are the standard medical terms used in the reports. Reports whose product could not be matched to a drug are not counted. Updated November 2026.